{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:45:32Z","timestamp":1784339132502,"version":"3.55.0"},"publisher-location":"Chichester, UK","reference-count":101,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004385.pub2","type":"reference-entry","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T13:18:45Z","timestamp":1120483125000},"source":"Crossref","is-referenced-by-count":12,"title":["Methotrexate for primary biliary cirrhosis"],"prefix":"10.1002","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,20]]},"reference":[{"issue":"4, Suppl. 1","key":"10.1002\/14651858.CD004385.pub2-BIB1|cit1","first-page":"211A","article-title":"The primary biliary cirrhosis (PBC) ursodiol (UDCA) plus methotrexate (MTX) or its placebo study (PUMPS) - a multicenter randomized trial (AASLD abstract)","volume":"38","author":"Combes","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl. 4","key":"10.1002\/14651858.CD004385.pub2-BIB2|cit2","first-page":"392A","article-title":"Absence of pulmonary toxicity in primary biliary cirrhosis (PBC) treated with methotrexate and ursodiol (AASLD abstract)","volume":"28","author":"Munoz","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-8278(01)81074-6","article-title":"Ursodeoxycholic acid and methotrexate for primary biliary cirrhosis (abstract)","volume":"34","author":"Copaci","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(97)80294-2","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone","volume":"27","author":"Gonzalez-Koch","year":"1997","journal-title":"Jounal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004385.pub2-BIB5|cit5","first-page":"A30","article-title":"Low-dose methotrexate in treatment of primary biliary cirrhosis (abstract)","volume":"36","author":"Giaffer","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD004385.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastraenterology"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004385.pub2-BIB7|cit7","first-page":"176A","article-title":"Double-blind trial of methotrexate (MTX) versus colchicine (COLCH) in primary biliary cirrhosis (PBC) (AASLD ABSTRACTS)","volume":"18","author":"Kaplan","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of priamry biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"issue":"9097","key":"10.1002\/14651858.CD004385.pub2-BIB11|cit9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(05)78176-9","article-title":"Primary biliary cirrhosis (letter)","volume":"17","author":"Kaplan","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub2-BIB9|cit10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.20103","article-title":"A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results","volume":"39","author":"Kaplan","year":"2004","journal-title":"Hepatology"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004385.pub2-BIB10|cit11","first-page":"152A","article-title":"Methotrexate (MTX) improves histology in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"20","author":"Kaplan","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB12|cit12","first-page":"518","article-title":"Synthesis of Interleukin-1beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchcine and disease progression","volume":"22","author":"Miller","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0016-5085(94)90085-X","article-title":"Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis","volume":"107","author":"Sharma","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB14|cit14","first-page":"342","article-title":"The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis","volume":"122","author":"Bach","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"4 Pt. 2","key":"10.1002\/14651858.CD004385.pub2-BIB15|cit15","first-page":"124A","article-title":"Two year histologic follow-up of the effects of methotrexate on primary biliary cirrhosis (AASLD abstract)","volume":"122","author":"Bach","year":"1995","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB16|cit16","first-page":"295","article-title":"Pilot study of low dose oral methotrxate treatment for primary biliary cirrhoiss","volume":"91","author":"Bergasa","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(05)80004-2","article-title":"Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone","volume":"18","author":"Buscher","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"5 Pt. 2","key":"10.1002\/14651858.CD004385.pub2-BIB19|cit19","first-page":"A720","article-title":"Oral methotrexate (MTX) for primary biliary cirrhosis (PBC): preliminary report (AASLD abstract)","volume":"100","author":"Bergasa","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0016-5085(91)90100-Y","article-title":"Methotrexate therapy of primary biliary cirrhosis: promising but worrisome","volume":"101","author":"Hoofnagle","year":"1991","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(92)91761-R","article-title":"Methotrexate for primary biliary cirrhosis (letter)","volume":"102","author":"Kaplan","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","article-title":"Primary biliary cirrhosis treated with low-dose oral pulse methotrexate","volume":"109","author":"Kaplan","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"Suupl.","key":"10.1002\/14651858.CD004385.pub2-BIB23|cit23","first-page":"92A","article-title":"The therapeutic effects of ursodiol and methotrexate are additive and well tolerated in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"16","author":"Kaplan","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB28|cit24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/hep.1840120427","article-title":"Methotrexate hepatotoxicity and the premature reporting or Mark Twain's death: both greatly exaggerated","volume":"12","author":"Kaplan","year":"1990","journal-title":"Hepatology"},{"issue":"268","key":"10.1002\/14651858.CD004385.pub2-BIB29|cit25","first-page":"757","article-title":"Methotrexate treatment of chronic cholestatic liver disease: friend or foe?","volume":"72","author":"Kaplan","year":"1989","journal-title":"Quarterly Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB30|cit26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007191","article-title":"The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis","volume":"17","author":"Kaplan","year":"1997","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD004385.pub2-BIB24|cit27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub2-BIB26|cit28","first-page":"585","article-title":"Effective treatment of pre-cirrhotic primary biliary cirrhosis (PBC) with methotrexate (MTX): remission in some (AASLD abstract)","volume":"10","author":"Kaplan","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB27|cit29","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB25|cit30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-109-5-429","article-title":"Primary biliary cirrhosis treated with low-dose oral pulse methotrexate","volume":"109","author":"Kaplan","year":"1988","journal-title":"Annals of Internal Medicine"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD004385.pub2-BIB31|cit31","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub2-BIB32|cit32","first-page":"157","article-title":"The combination of ursodeoxycholic acid (UDCA) and methotrexate (MTX) for patients with primary biliary cirrhosis (PBC): the results of a pilot study (AASLD abstract)","volume":"20","author":"Lindor","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB33|cit33","first-page":"S41","article-title":"One year treatment with methotrexate (MTX) in patients with primary biliary cirrhosis (PBC) (abstract)","volume":"16","author":"Steenbergen","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB34|cit34","first-page":"246","article-title":"Methrotrexate alone or in combination with ursodeoxycholic acid as possible treatment in primary biliary cirrhosis","volume-title":"Cholestatic Liver diseases: New Strategies for Prevention and Treatment of Hepatobiliary and Cholestatic Liver Diseases. Falk Symposium 75","author":"Steenbergen","year":"1994"},{"key":"10.1002\/14651858.CD004385.pub2-BIB35|cit35","series-title":"Kinische Hepatologie","first-page":"6","article-title":"Methotrexate in primary biliary cirrhosis and sclerosing cholangitis","author":"Steenbergen","year":"1995"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/17843286.1996.11718480","article-title":"Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis","volume":"51","author":"Steenbergen","year":"1996","journal-title":"Acta Clinica Belgica"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004385.pub2-BIB37|cit37","first-page":"187","article-title":"Combined treatment with methotrexate and ursodeoxycholic acid in primary biliary cirrhosis (PBC) (EASL abstract)","volume":"21","author":"Steenbergen","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub2-BIB38|cit38","first-page":"A1406","article-title":"Methotrexate therapy in primary biliary cirrhosis is of limited efficacy and accompanied by serious side effects (AASLD abstract)","volume":"112","author":"Vandeputte","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB39|cit39","article-title":"Cochrane Reviewers' Handbook 4.2.1[updated December 2003]","author":"Alderson","year":"2004","journal-title":"The Cochrane Library"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB40|cit40","article-title":"Methotrexate for induction of remission in refractory Crohn's disease (Cochrane Review)","author":"Alfadhli","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004385.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revistied: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004385.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(84)91108-5","article-title":"Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis","volume":"ii","author":"Ballardini","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004385.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD004385.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis: a progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB47|cit47","article-title":"Antimetabolites","volume-title":"Cancer Chemotherapy: Principles and Practice","author":"Chu","year":"1995"},{"key":"10.1002\/14651858.CD004385.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"124A","DOI":"10.1016\/0270-9139(95)94219-X","article-title":"Methotrexate therapy of primary biliary cirrhosis: 2 yr study comparing two different doses (abstract)","volume":"22","author":"Conjeevaram","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB49|cit49","article-title":"Methotrexate as a steroid sparing agent for asthma in adults (Cochrane Review)","author":"Davies","year":"2004","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"16","key":"10.1002\/14651858.CD004385.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD004385.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"8233","key":"10.1002\/14651858.CD004385.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004385.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0016-5085(82)80125-X","article-title":"The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"83","author":"Epstein","year":"1982","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators","volume":"332","author":"Feagan","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004385.pub2-BIB56|cit56","first-page":"A1121","article-title":"Antimitochondrial antibodies AMA of primary biliary cirrhosis PBC recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha ketoacid dehydrogenase complex","volume":"3","author":"Fregeau","year":"1989","journal-title":"Faseb Journal"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB57|cit57","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"2002","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB58|cit58","article-title":"Methotrexate for primary biliary cirrhosis (protocol)","author":"Gong","year":"2003","journal-title":"The Cochrane Library"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB59|cit59","article-title":"Colchicine for primary biliary cirrhosis","author":"Gong","year":"2004","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB60|cit60","article-title":"D-penicillamine for primary biliary cirrhosis","author":"Gong","year":"2004","journal-title":"The Cochrane Library"},{"issue":"5 Pt. 1","key":"10.1002\/14651858.CD004385.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004385.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD004385.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB65|cit65","volume-title":"Code of Federal Regulation & ICH Guidelines","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","article-title":"Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses","volume":"98","author":"Ioannidis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8233","key":"10.1002\/14651858.CD004385.pub2-BIB68|cit68","first-page":"1278","article-title":"Primary biliary cirrhosis - a revised clinical spectrum","volume":"1","author":"James","year":"1981","journal-title":"Lancet"},{"issue":"19","key":"10.1002\/14651858.CD004385.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199405123301912","article-title":"Primary biliary cirrhosis - a first step in prolonging survival","volume":"330","author":"Kaplan","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD004385.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004385.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a U.S. community","volume":"119","author":"Kim","year":"2000","journal-title":"Gatroenterology"},{"issue":"11","key":"10.1002\/14651858.CD004385.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB73|cit73","first-page":"247","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"90","author":"Lacerda","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/sim.1300","article-title":"Combined endpoints: can we use them?","volume":"21","author":"Lubsen","year":"2002","journal-title":"Statistics in medicine"},{"key":"10.1002\/14651858.CD004385.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004385.pub2-BIB76|cit76","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD004385.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"issue":"9039","key":"10.1002\/14651858.CD004385.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004385.pub2-BIB80|cit80","first-page":"S86","article-title":"Methotrexate inhibits interleukin-1 activity","volume":"29","author":"Miller","year":"1986","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"9128","key":"10.1002\/14651858.CD004385.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004385.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","article-title":"Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease","volume":"24","author":"Nyberg","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in medicine"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD004385.pub2-BIB87|cit87","first-page":"171A","article-title":"Symptom development and prognosis of initially asymptomatic PBC","volume":"32","author":"Prince","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gatroenterology"},{"key":"10.1002\/14651858.CD004385.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clinics in Liver Disease"},{"issue":"12","key":"10.1002\/14651858.CD004385.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB92|cit92","article-title":"Methotrexate for treating rheumatoid arthritis (Cochrane Review)","author":"Suarez-Almazor","year":"2004","journal-title":"The Cochrane Library"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB93|cit93","article-title":"Methotrexate for treating juvenile idiopathic arthritis (Cochrane Review)","author":"Takken","year":"2004","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004385.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1365-2036.1996.70244000.x","article-title":"Review article: methotrexate in gastroenterology - dangerous villain or simply misunderstood?","volume":"10","author":"Tang","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB95|cit95","first-page":"124","article-title":"A study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0168-8278(86)80483-4","article-title":"Expression of MHC products by normal and abnormal bile duct epithelium","volume":"3","author":"Oord","year":"1986","journal-title":"Jounal of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD004385.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004385.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD004385.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Jounal of Hepatology"},{"issue":"20","key":"10.1002\/14651858.CD004385.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004385.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.1840060309","article-title":"Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis","volume":"6","author":"Yamada","year":"1986","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004385.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T00:00:00Z","timestamp":1273622400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004385.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:34:20Z","timestamp":1628530460000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004385.pub2"}},"subtitle":[],"editor":[{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,7,20]]},"references-count":101,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004385.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004385.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2005,7,20]]}}}